Compare, Analyse AANJANEYA LIFECARE with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   MYLAN
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
MYLAN
Dec-18
DR. DATSONS LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1263,554-   
Low Rs311,956-   
Sales per share (Unadj.) Rs133.01,635.5-  
Earnings per share (Unadj.) Rs0.244.4-  
Cash flow per share (Unadj.) Rs6.6350.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.81,769.3-  
Shares outstanding (eoy) m31.66514.50-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.7 34.9%   
Avg P/E ratio x516.162.0 831.9%  
P/CF ratio (eoy) x11.87.9 150.7%  
Price / Book Value ratio x0.61.6 39.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4771,417,614 0.2%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m560-   
Avg. sales/employee Rs ThNM24,041.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM652.8-  
INCOME DATA
Net Sales Rs m4,211841,456 0.5%  
Other income Rs m790-   
Total revenues Rs m4,289841,456 0.5%   
Gross profit Rs m569217,738 0.3%  
Depreciation Rs m204157,554 0.1%   
Interest Rs m43040,471 1.1%   
Profit before tax Rs m1319,713 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-3,136 -0.2%   
Profit after tax Rs m522,849 0.0%  
Gross profit margin %13.525.9 52.2%  
Effective tax rate %48.0-15.9 -301.9%   
Net profit margin %0.12.7 4.2%  
BALANCE SHEET DATA
Current assets Rs m6,852469,868 1.5%   
Current liabilities Rs m6,711342,586 2.0%   
Net working cap to sales %3.315.1 22.1%  
Current ratio x1.01.4 74.4%  
Inventory Days Days16184 192.5%  
Debtors Days Days31893 341.3%  
Net fixed assets Rs m3,673163,229 2.3%   
Share capital Rs m317448 70.7%   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,078910,302 0.4%   
Long term debt Rs m1,671982,508 0.2%   
Total assets Rs m12,6332,441,784 0.5%  
Interest coverage x1.01.5 69.2%   
Debt to equity ratio x0.41.1 38.0%  
Sales to assets ratio x0.30.3 96.7%   
Return on assets %3.42.6 132.8%  
Return on equity %0.12.5 4.7%  
Return on capital %7.73.2 241.3%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,345174,855 0.8%  
From Investments Rs m-2,256-90,381 2.5%  
From Financial Activity Rs m-1,200-81,458 1.5%  
Net Cashflow Rs m-2,1111,449 -145.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.67 Rs / USD

Compare DR. DATSONS LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. DATSONS LABS With: CIPLA  WYETH  STERLING BIOTECH  ALEMBIC PHARMA  PROCTER & GAMBLE HEALTH  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views On News

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS